ID   UACC-502
AC   CVCL_M458
SY   UACC 502; UACC502; University of Arizona Cell Culture-502
DR   BTO; BTO:0005898
DR   Wikidata; Q54973852
RX   PubMed=9973934;
RX   PubMed=10952317;
RX   PubMed=12115485;
RX   PubMed=24879157;
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
RX   PubMed=9973934; DOI=10.1016/S0165-4608(98)00122-8;
RA   Nelson M.A., Ariza M.E., Yang J.-M., Thompson F.H., Taetle R.,
RA   Trent J.M., Wymer J., Massey-Brown K.S., Broome-Powell M., Easton J.,
RA   Lahti J.M., Kidd V.J.;
RT   "Abnormalities in the p34cdc2-related PITSLRE protein kinase gene
RT   complex (CDC2L) on chromosome band 1p36 in melanoma.";
RL   Cancer Genet. Cytogenet. 108:91-99(1999).
//
RX   PubMed=10952317; DOI=10.1038/35020115;
RA   Bittner M., Meltzer P.S., Chen Y.-D., Jiang Y., Seftor E.A.,
RA   Hendrix M.J.C., Radmacher M.D., Simon R.M., Yakhini Z., Ben-Dor A.,
RA   Sampas N., Dougherty E., Wang E., Marincola F.M., Gooden G.C., Lueders J.,
RA   Glatfelter A., Pollock P.M., Carpten J.D., Gillanders E.M., Leja D.,
RA   Dietrich K., Beaudry C., Berens M.E., Alberts D.S., Sondak V.K.,
RA   Hayward N.K., Trent J.M.;
RT   "Molecular classification of cutaneous malignant melanoma by gene
RT   expression profiling.";
RL   Nature 406:536-540(2000).
//
RX   PubMed=12115485; DOI=10.1002/ijc.10422;
RA   Feng Y.-M., Shi J.-Q., Goldstein A.M., Tucker M.A., Nelson M.A.;
RT   "Analysis of mutations and identification of several polymorphisms in
RT   the putative promoter region of the P34CDC2-related CDC2L1 gene
RT   located at 1P36 in melanoma cell lines and melanoma families.";
RL   Int. J. Cancer 99:834-838(2002).
//
RX   PubMed=24879157; DOI=10.4161/auto.28594; PMCID=PMC4091172;
RA   Goodall M.L., Wang T., Martin K.R., Kortus M.G., Kauffman A.L.,
RA   Trent J.M., Gately S., MacKeigan J.P.;
RT   "Development of potent autophagy inhibitors that sensitize oncogenic
RT   BRAF V600E mutant melanoma tumor cells to vemurafenib.";
RL   Autophagy 10:1120-1136(2014).
//